It has been revealed that silencing of GFR genes reduced cell viability (CV), with the highest cytotoxicity observed with the siRNAs targeting egfr1 and erbb2 genes, enhanced apoptotic signal in the cells and also reduced the tumor volume in mice, with exception of igf1r gene knockdown. Here, ERBB2 is linked to neoplasm.